Company Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States.
The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics.
The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies.
It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities.
The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017.
Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
| Country | United States |
| Founded | 2008 |
| IPO Date | Jul 25, 2019 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,200 |
| CEO | Benjamin Albert |
Contact Details
Address: 10897 South River Front Parkway, Suite 300 South Jordan, Utah 84095 United States | |
| Phone | 801 708 6800 |
| Website | healthcatalyst.com |
Stock Details
| Ticker Symbol | HCAT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $26.00 |
| CIK Code | 1636422 |
| CUSIP Number | 42225T107 |
| ISIN Number | US42225T1079 |
| Employer ID | 45-3337483 |
| SIC Code | 7370 |
Key Executives
| Name | Position |
|---|---|
| Benjamin Albert | Chief Executive Officer and Director |
| Jason Alger | Chief Financial Officer |
| Benjamin Landry | General Counsel and Secretary of the Board |
| Kyle J. Salyers | Chief Strategy Officer and Senior Vice President of Corporate Development |
| Carrie Kozlowski OT | Chief Marketing Officer |
| Jeffrey P. Selander | Senior Vice President of International |
| Holly Rimmasch | Senior Vice President and Chief Clinical Officer |
| Linda Llewelyn | Senior Advisor |
| Sadiqa Mahmood D.D.S., M.P.H. | GM and Senior Vice President of Life Sciences Business |
| Kristen Berry | Senior Vice President of Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 10, 2026 | 144 | Filing |
| Jun 8, 2026 | SCHEDULE 13D/A | Filing |
| Jun 4, 2026 | 8-K | Current Report |
| Jun 3, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 3, 2026 | DEF 14A | Other definitive proxy statements |
| Jun 1, 2026 | 144 | Filing |
| Jun 1, 2026 | 144 | Filing |
| Jun 1, 2026 | 144 | Filing |
| Jun 1, 2026 | 144 | Filing |
| May 19, 2026 | PRE 14A | Other preliminary proxy statements |